We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFTX
5151
Definium Therapeutics
DFTX
$6.12B
$407K ﹤0.01%
56,488
+32,104
+132% +$281K
CHPT icon
5152
ChargePoint
CHPT
$161M
$407K ﹤0.01%
13,483
-2,787
-17% -$90.7K
DAKT icon
5153
Daktronics
DAKT
$1.04B
$407K ﹤0.01%
29,183
-25,348
-46% -$271K
CERS icon
5154
Cerus
CERS
$474M
$406K ﹤0.01%
230,438
-118,570
-34% -$212K
CMBT
5155
CMB.TECH NV
CMBT
$4.73B
$404K ﹤0.01%
24,442
+12,703
+108% +$216K
GLAD icon
5156
Gladstone Capital
GLAD
$446M
$403K ﹤0.01%
17,316
+6,994
+68% +$153K
OLO
5157
DELISTED
Olo Inc
OLO
$402K ﹤0.01%
91,030
-37,049
-29% -$175K
DIHP icon
5158
Dimensional International High Profitability ETF
DIHP
$6.59B
$402K ﹤0.01%
15,284
+291
+2% +$7.73K
HEQ
5159
John Hancock Hedged Equity & Income Fund
HEQ
$140M
$401K ﹤0.01%
38,632
+5,210
+16% +$53.3K
OPPE
5160
WisdomTree European Opportunities Fund
OPPE
$295M
$400K ﹤0.01%
10,626
-925
-8% -$36.3K
TMF icon
5161
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.18B
$400K ﹤0.01%
8,247
+173
+2% +$8.39K
FLGT icon
5162
Fulgent Genetics
FLGT
$527M
$400K ﹤0.01%
20,378
-6,752
-25% -$141K
PGY icon
5163
Pagaya Technologies
PGY
$1.78B
$400K ﹤0.01%
31,312
-20,637
-40% -$232K
HAPN
5164
Happen Inc
HAPN
$2.24B
$399K ﹤0.01%
47,161
-94,982
-67% -$813K
WTTR icon
5165
Select Water Solutions
WTTR
$2.61B
$398K ﹤0.01%
37,237
-21,047
-36% -$208K
ISHG icon
5166
iShares 1-3 Year International Treasury Bond ETF
ISHG
$828M
$397K ﹤0.01%
5,708
+3,247
+132% +$226K
LYTS icon
5167
LSI Industries
LYTS
$924M
$394K ﹤0.01%
27,231
-16,688
-38% -$252K
ERO icon
5168
Ero Copper
ERO
$3.58B
$394K ﹤0.01%
18,428
-1,504
-8% -$31.5K
ASG
5169
Liberty All-Star Growth Fund
ASG
$341M
$392K ﹤0.01%
73,412
-209
-0.3% -$1.1K
PETQ
5170
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$392K ﹤0.01%
17,751
-16,076
-48% -$309K
FTXL icon
5171
First Trust Nasdaq Semiconductor ETF
FTXL
$1.36B
$391K ﹤0.01%
3,920
+2,630
+204% +$242K
ALX
5172
Alexander's
ALX
$1.41B
$391K ﹤0.01%
1,738
-1,582
-48% -$341K
CCI icon
5173
PUT
Crown Castle
CCI
$32.2B
$391K ﹤0.01%
+4,000
New +$394K
GTX icon
5174
Garrett Motion
GTX
$5.57B
$390K ﹤0.01%
45,439
-12,113
-21% -$112K
POWA icon
5175
Invesco Bloomberg Pricing Power ETF
POWA
$183M
$390K ﹤0.01%
5,020
-737
-13% -$56.7K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.